Clinical Trial Update: A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating risk-factor–driven treatment for children with favorable-histology Wilms tumors. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilms Tumor

Snippet

Sponsor: Children's Oncology Group | Conditions: Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor | Phase 3 | Status: RECRUITING